Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Age group and sex differences in performance on a computerized neurocognitive battery in children age 8-21.

Gur RC, Richard J, Calkins ME, Chiavacci R, Hansen JA, Bilker WB, Loughead J, Connolly JJ, Qiu H, Mentch FD, Abou-Sleiman PM, Hakonarson H, Gur RE.

Neuropsychology. 2012 Mar;26(2):251-265. doi: 10.1037/a0026712. Epub 2012 Jan 16.

2.

Transcriptional repression of p53 by parkin and impairment by mutations associated with autosomal recessive juvenile Parkinson's disease.

da Costa CA, Sunyach C, Giaime E, West A, Corti O, Brice A, Safe S, Abou-Sleiman PM, Wood NW, Takahashi H, Goldberg MS, Shen J, Checler F.

Nat Cell Biol. 2009 Nov;11(11):1370-5. doi: 10.1038/ncb1981. Epub 2009 Oct 4.

3.

Association of MAPT haplotype-tagging SNPs with sporadic Parkinson's disease.

Vandrovcova J, Pittman AM, Malzer E, Abou-Sleiman PM, Lees AJ, Wood NW, de Silva R.

Neurobiol Aging. 2009 Sep;30(9):1477-82. Epub 2007 Dec 26.

PMID:
18162161
4.

Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption.

McKenzie M, Liolitsa D, Akinshina N, Campanella M, Sisodiya S, Hargreaves I, Nirmalananthan N, Sweeney MG, Abou-Sleiman PM, Wood NW, Hanna MG, Duchen MR.

J Biol Chem. 2007 Dec 21;282(51):36845-52. Epub 2007 Oct 16.

5.

Genetic association studies of complex neurological diseases.

Abou-Sleiman PM, Hanna MG, Wood NW.

J Neurol Neurosurg Psychiatry. 2006 Dec;77(12):1302-4. Review.

6.

NR4A2 genetic variation in sporadic Parkinson's disease: a genewide approach.

Healy DG, Abou-Sleiman PM, Ahmadi KR, Gandhi S, Muqit MM, Bhatia KP, Quinn NP, Lees AJ, Holton JL, Revesz T, Wood NW.

Mov Disord. 2006 Nov;21(11):1960-3.

PMID:
16977628
7.

A heterozygous effect for PINK1 mutations in Parkinson's disease?

Abou-Sleiman PM, Muqit MM, McDonald NQ, Yang YX, Gandhi S, Healy DG, Harvey K, Harvey RJ, Deas E, Bhatia K, Quinn N, Lees A, Latchman DS, Wood NW.

Ann Neurol. 2006 Oct;60(4):414-9.

PMID:
16969854
8.

Expanding the phenotypes of the Pro56Ser VAPB mutation: proximal SMA with dysautonomia.

Marques VD, Barreira AA, Davis MB, Abou-Sleiman PM, Silva WA Jr, Zago MA, Sobreira C, Fazan V, Marques W Jr.

Muscle Nerve. 2006 Dec;34(6):731-9.

PMID:
16967488
9.

Altered cleavage and localization of PINK1 to aggresomes in the presence of proteasomal stress.

Muqit MM, Abou-Sleiman PM, Saurin AT, Harvey K, Gandhi S, Deas E, Eaton S, Payne Smith MD, Venner K, Matilla A, Healy DG, Gilks WP, Lees AJ, Holton J, Revesz T, Parker PJ, Harvey RJ, Wood NW, Latchman DS.

J Neurochem. 2006 Jul;98(1):156-69.

10.

PINK1 protein in normal human brain and Parkinson's disease.

Gandhi S, Muqit MM, Stanyer L, Healy DG, Abou-Sleiman PM, Hargreaves I, Heales S, Ganguly M, Parsons L, Lees AJ, Latchman DS, Holton JL, Wood NW, Revesz T.

Brain. 2006 Jul;129(Pt 7):1720-31. Epub 2006 May 15.

PMID:
16702191
11.

The alpha-synuclein gene in multiple system atrophy.

Ozawa T, Healy DG, Abou-Sleiman PM, Ahmadi KR, Quinn N, Lees AJ, Shaw K, Wullner U, Berciano J, Moller JC, Kamm C, Burk K, Josephs KA, Barone P, Tolosa E, Goldstein DB, Wenning G, Geser F, Holton JL, Gasser T, Revesz T, Wood NW; European MSA study group.

J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):464-7.

12.

Expanding insights of mitochondrial dysfunction in Parkinson's disease.

Abou-Sleiman PM, Muqit MM, Wood NW.

Nat Rev Neurosci. 2006 Mar;7(3):207-19. Review.

PMID:
16495942
13.

UCHL-1 is not a Parkinson's disease susceptibility gene.

Healy DG, Abou-Sleiman PM, Casas JP, Ahmadi KR, Lynch T, Gandhi S, Muqit MM, Foltynie T, Barker R, Bhatia KP, Quinn NP, Lees AJ, Gibson JM, Holton JL, Revesz T, Goldstein DB, Wood NW.

Ann Neurol. 2006 Apr;59(4):627-33.

PMID:
16450370
14.

Population genetic approaches to neurological disease: Parkinson's disease as an example.

Gandhi S, Abou-Sleiman PM, Healy DG, Weale M, Gilks W, Ahmadi K, Goldstein DB, Wood NW.

Philos Trans R Soc Lond B Biol Sci. 2005 Aug 29;360(1460):1573-8. Review.

15.

UCHL-1 gene in multiple system atrophy: a haplotype tagging approach.

Healy DG, Abou-Sleiman PM, Quinn N, Ahmadi KR, Ozawa T, Kamm C, Wullner U, Oertel WH, Burk K, Dupont E, Pellecchia MT, Tolosa E, Gasser T, Holton JL, Revesz T, Goldstein DB, Lees AJ, Wood NW; European MSA Study Group.

Mov Disord. 2005 Oct;20(10):1338-43.

PMID:
16007636
16.

Commentary on "A genome wide linkage disequilibrium screen in Parkinson's disease" by Foltynie et al. in J Neurol (2005) 252:597-602.

Wood NW, Healy DG, Depondt C, Abou-Sleiman PM.

J Neurol. 2005 May;252(5):603-4. Epub 2005 Mar 7. No abstract available.

PMID:
15742113
17.

A common LRRK2 mutation in idiopathic Parkinson's disease.

Gilks WP, Abou-Sleiman PM, Gandhi S, Jain S, Singleton A, Lees AJ, Shaw K, Bhatia KP, Bonifati V, Quinn NP, Lynch J, Healy DG, Holton JL, Revesz T, Wood NW.

Lancet. 2005 Jan 29-Feb 4;365(9457):415-6.

PMID:
15680457
18.

Hereditary motor and autonomic neuronopathy 1 maps to chromosome 20q13.2-13.3.

Marques W Jr, Davis MB, Abou-Sleiman PM, Marques VD, Silva WA Jr, Zago MA, Sobreira CS, Barreira AA.

Braz J Med Biol Res. 2004 Nov;37(11):1757-62. Epub 2004 Oct 26.

19.

PINK1 (PARK6) associated Parkinson disease in Ireland.

Healy DG, Abou-Sleiman PM, Gibson JM, Ross OA, Jain S, Gandhi S, Gosal D, Muqit MM, Wood NW, Lynch T.

Neurology. 2004 Oct 26;63(8):1486-8.

PMID:
15505171
20.

Causes of Parkinson's disease: genetics of DJ-1.

Abou-Sleiman PM, Healy DG, Wood NW.

Cell Tissue Res. 2004 Oct;318(1):185-8. Epub 2004 Jun 26. Review.

PMID:
15503154
21.

Genetic approaches to solving common diseases.

Abou-Sleiman PM, Healy DG, Wood NW.

J Neurol. 2004 Oct;251(10):1169-72. Review.

PMID:
15503093
22.

PINK, PANK, or PARK? A clinicians' guide to familial parkinsonism.

Healy DG, Abou-Sleiman PM, Wood NW.

Lancet Neurol. 2004 Nov;3(11):652-62. Review.

PMID:
15488458
23.

The gene responsible for PARK6 Parkinson's disease, PINK1, does not influence common forms of parkinsonism.

Healy DG, Abou-Sleiman PM, Ahmadi KR, Muqit MM, Bhatia KP, Quinn NP, Lees AJ, Latchmann DS, Goldstein DB, Wood NW.

Ann Neurol. 2004 Sep;56(3):329-35.

PMID:
15349859
24.

Population genetics for target identification.

Healy DG, Abou-Sleiman PM, Goldstein DB, Wood NW.

Drug Discov Today Technol. 2004 Sep;1(1):69-74. doi: 10.1016/j.ddtec.2004.08.012.

PMID:
24981270
25.

Genetic causes of Parkinson's disease: UCHL-1.

Healy DG, Abou-Sleiman PM, Wood NW.

Cell Tissue Res. 2004 Oct;318(1):189-94. Epub 2004 Jun 19. Review.

PMID:
15221445
26.

Assessment of a DJ-1 (PARK7) polymorphism in Finnish PD.

Healy DG, Abou-Sleiman PM, Jain S, Ahmadi KR, Wood NW.

Neurology. 2004 Jun 22;62(12):2335. No abstract available.

PMID:
15210917
27.

Tau gene and Parkinson's disease: a case-control study and meta-analysis.

Healy DG, Abou-Sleiman PM, Lees AJ, Casas JP, Quinn N, Bhatia K, Hingorani AD, Wood NW.

J Neurol Neurosurg Psychiatry. 2004 Jul;75(7):962-5.

28.

Hereditary early-onset Parkinson's disease caused by mutations in PINK1.

Valente EM, Abou-Sleiman PM, Caputo V, Muqit MM, Harvey K, Gispert S, Ali Z, Del Turco D, Bentivoglio AR, Healy DG, Albanese A, Nussbaum R, González-Maldonado R, Deller T, Salvi S, Cortelli P, Gilks WP, Latchman DS, Harvey RJ, Dallapiccola B, Auburger G, Wood NW.

Science. 2004 May 21;304(5674):1158-60. Epub 2004 Apr 15.

29.

A functional polymorphism regulating dopamine beta-hydroxylase influences against Parkinson's disease.

Healy DG, Abou-Sleiman PM, Ozawa T, Lees AJ, Bhatia K, Ahmadi KR, Wullner U, Berciano J, Moller JC, Kamm C, Burk K, Barone P, Tolosa E, Quinn N, Goldstein DB, Wood NW.

Ann Neurol. 2004 Mar;55(3):443-6. Erratum in: Ann Neurol. 2004 Aug;56(2):311. Barrone P [corrected to Barone P].

PMID:
14991826
30.

DJ-1 mutations in Parkinson's disease.

Healy DG, Abou-Sleiman PM, Valente EM, Gilks WP, Bhatia K, Quinn N, Lees AJ, Wood NW.

J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):144-5.

31.

The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.

Bandopadhyay R, Kingsbury AE, Cookson MR, Reid AR, Evans IM, Hope AD, Pittman AM, Lashley T, Canet-Aviles R, Miller DW, McLendon C, Strand C, Leonard AJ, Abou-Sleiman PM, Healy DG, Ariga H, Wood NW, de Silva R, Revesz T, Hardy JA, Lees AJ.

Brain. 2004 Feb;127(Pt 2):420-30. Epub 2003 Dec 8.

PMID:
14662519
32.

The role of pathogenic DJ-1 mutations in Parkinson's disease.

Abou-Sleiman PM, Healy DG, Quinn N, Lees AJ, Wood NW.

Ann Neurol. 2003 Sep;54(3):283-6.

PMID:
12953260
33.

First application of preimplantation genetic diagnosis to neurofibromatosis type 2 (NF2).

Abou-Sleiman PM, Apessos A, Harper JC, Serhal P, Winston RM, Delhanty JD.

Prenat Diagn. 2002 Jun;22(6):519-24.

PMID:
12116319
34.

Pregnancy following preimplantation genetic diagnosis for Crouzon syndrome.

Abou-Sleiman PM, Apessos A, Harper JC, Serhal P, Delhanty JD.

Mol Hum Reprod. 2002 Mar;8(3):304-9.

PMID:
11870239
35.

Preimplantation genetic diagnosis of the fragile X syndrome by use of linked polymorphic markers.

Apessos A, Abou-Sleiman PM, Harper JC, Delhanty JD.

Prenat Diagn. 2001 Jun;21(6):504-11.

PMID:
11438958

Supplemental Content

Loading ...
Support Center